Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early very high-titre convalescent plasma for clinically vulnerable adults with mild COVID-19 in Germany
2021-006621-22Phase 3Completed
- Sponsor
- DRK-Blutspendedienst Baden-Württemberg-Hessen
- Start
- Dec 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in coronavirus disease 2019 (COVID-19) comparing COVID-19 convalescent plasma + standard of care with Standard of care alone (2 arms). Started Dec 2021; status: completed.
02
Drugs
COVID-19 convalescent plasma
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2021-006621-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-006621-22.